CLI Ventures
VC Fund
Palo Alto, United States
CLI Ventures is a global venture capital and private equity investment firm committed to helping exceptional entrepreneurs build the next generation of great healthcare and data analytics companies. The firm invests across the healthcare sector and at all stages of company development, with an emphasis on the discovery and development of noveldiagnostics, therapeutics, and data applications. With $1 billion under management and offices in Palo Alto, New York, Boston, San Diego, Los Angeles, Beijing, Shanghai, Shenzhen, and Wuhan. CLI has built a team with deep investment, operating, and scientific expertise that enables a hands-on approach to company building. CLI affiliated funds have been involved in the formation of more than 200 portfolio companies. Our companies have created a number of U.S. and China approved products that have advanced human health. CLI has developed innovative investment models, such as U.S.-China cross-border licensing, which have proven successful and have been widely emulated in the life science industry. CLI is engaged in new collaborations, including CLI’s investments in China with the health ministries and departments and local government at city and province levels, respectively.
- Total investments:
- 22
- Last investment:
- Lead investor:
- 5%
- Fund size:
- $200M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries CLI Ventures invests in
Stages CLI Ventures invests in
Countries CLI Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Zhi Li
|
|||
Zhongmin Pi
|
|||
Investment Focus
Industry
- Biotechnology 5 (23%)
- Software 4 (18%)
- Robotics 3 (14%)
- Health Care 3 (14%)
- Mobile 2 (9%)
Stage
- Seed 9 (41%)
- Series A 4 (18%)
- Convertible Note 3 (14%)
- Pre-Seed 1 (5%)
- Series B 1 (5%)
Country
- United States 18 (82%)
- Germany 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Zhi Li
Managing Partner
|
Managing Partner | Total investments: 1 | Find email | |
|
Zhongmin Pi
Venture Partner (Self employed)
|
Venture Partner (Self employed) | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Immune-Onc Therapeutics is a newly established bio-pharmaceutical company that focuses on developing innovative therapeutic antibodies for cancer treatment. The company applies the latest scientific insights and expertise in drug development to advance novel immuno-oncology products and bring new treatment options to cancer patients. | $7M / Series A / Sep 01, 2016 | ||
| Eonite is on a mission to enable machines to understand the real world – to give computers the advanced perception necessary for the future of VR, AR, robots and drones. They are looking for people who will help us build, refine, and deliver the tech that achieves their goals. They offer competitive salaries, great equity packages, and fullbenefits. They are always looking for smart, talented people who are nice adults motivated to make a difference. They’re based in Palo Alto, but their team is global. So reach out, even if the openings aren’t a perfect fit.. | $5.3M / Seed / May 05, 2016 | ||
| Headquartered in Berlin, Medigo enables global access to quality healthcare. As a third party administrator (TPA), Medigo helps organisations navigate healthcare across the globe with an international provider network, tech-driven cost containment, and an excellent member experience. Medigo is supported by leading VCs such as Accel Partners andAtlantic Labs, and employs a driven team of 50+ people from 25 countries. | $3.7M / Series A / Jan 19, 2016 | ||
| Aria Pharmaceuticals is a preclinical-stage pharmaceutical company discovering and developing novel small molecule therapies for complex and hard-to-treat diseases. Too many patients today are in need of breakthrough treatments across many complicated diseases – they can't wait. That's why at Aria, we have redefined the drug discoveryapproach, saving years in the process and increasing success rates 30 times higher than traditional methods. At Aria, we've shown promise across a diverse range of therapeutic areas with the ability to address over 1,000 diseases. | $3.4M / Seed / Nov 19, 2015 | ||
| The Civil Maps sensor-agnostic platform enables high-accuracy, low-cost 3D HD mapping and localization at scale. Auto OEMs, mapping companies, and mobility providers use our technology to advance their autonomous driving initiatives by integrating our localization technology with their decision-making stack and sensor configurations of choice.Civil Maps enables vehicles to develop and leverage their own “mental model” of the world; they can can create, utilize, and create maps with the industry’s most cost-effective, scalable, and robust methods available today. Civil Maps’ proprietary Fingerprint Basemap Technology is at the core of our offerings in sensor fusion, 3D mapping, centimeter-accurate localization at scale. While empowering vehicles with full environmental awareness and enhanced safety, Civil Maps is able to dramatically reduce the cost, compute, and energy requirements involved in continental-scale deployment of delivery bots and autonomous vehicles. | $1.5M / Convertible Note / Sep 12, 2015 | ||
| Flirtey provides drone delivery service of retail and e-commerce items to consumer homes. It is driven by a mission to improve lifestyles by making delivery instant for everyone.The company was the first to conduct an FAA-approved drone delivery in the U.S., the first to perform a fully autonomous drone delivery to a home and the first to launcha commercial drone delivery service.Flirtey was founded in 2013 and is headquartered in Reno, Nevada. | Sep 07, 2015 | ||
| Genalyte, Inc. is a life sciences company developing and commercializing innovative next-generation multiplexing technology. Genalyte has developed a new approach to immunodetection using silicon chip manufacturing methods. Its Maverick platform uses a technology called silicon photonics to directly measure protein binding between antibodies andantigens or hybridization of nucleic acids. | $44M / Series C / Aug 18, 2015 | ||
| Flirtey provides drone delivery service of retail and e-commerce items to consumer homes. It is driven by a mission to improve lifestyles by making delivery instant for everyone.The company was the first to conduct an FAA-approved drone delivery in the U.S., the first to perform a fully autonomous drone delivery to a home and the first to launcha commercial drone delivery service.Flirtey was founded in 2013 and is headquartered in Reno, Nevada. | $120K / Seed / Aug 18, 2015 | ||
| Industrial Microbes designs and builds microbes that produce better chemicals with lower costs and lower carbon emissions. We use greenhouse gases as the raw materials, including biogas, natural gas, and carbon dioxide. We scale our process with global chemical producers. | $120K / Pre-Seed / Jun 15, 2015 | ||
| CoPromote is a social exchange platform to help people grow their audience. Users are content creators ranging from artists, bloggers, brands, businesses, musicians, tastemakers, websites, and more. CoPromote is for people of all interest types. | $480.6K / Series A / Jun 02, 2015 | ||
| See all 22 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does CLI Ventures invest in?
CLI Ventures invests primarily in Biotechnology, Software and Robotics startups, most often at Seed and Series A stage. Most of the 22 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact CLI Ventures?
Public channels for CLI Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at CLI Ventures?
The team at CLI Ventures includes Zhi Li (Managing Partner) and Zhongmin Pi (Venture Partner (Self employed)). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
